Anna M. Becker
Basel, BS 4012, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
LSD therapy: A few hundred meters from where it began.
Journal: Med (New York, N.Y.)
Published: June 29, 2026
The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.
Journal: Journal of psychopharmacology (Oxford, England)
Published: December 26, 2025
Comparison of acute effects of 3,4-methylenedioxymethamphetamine (MDMA) with and without a supplemental booster dose in healthy participants: a double-blind, randomized, placebo-controlled, crossover study.
Journal: Translational psychiatry
Published: November 25, 2025
Low-dose lysergic acid diethylamide alters subjective visual perception but not visual contrast surround suppression.
Journal: Neuroscience of consciousness
Published: November 13, 2025
Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants.
Journal: Clinical pharmacokinetics
Published: June 22, 2025
Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.
Journal: International journal of methods in psychiatric research
Published: June 09, 2025
Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.
Journal: Clinical pharmacology and therapeutics
Published: November 11, 2024
Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: October 04, 2024
Last Updated: 09/26/2026